These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Low-dose cyclosporine A in severe psoriasis. Marks J Transplant Proc; 1988 Jun; 20(3 Suppl 4):68-71. PubMed ID: 3381305 [TBL] [Abstract][Full Text] [Related]
11. Low-dose cyclosporine effective in severe psoriasis: a double-blind study. Heule F; Meinardi MM; van Joost T; Bos JD Transplant Proc; 1988 Jun; 20(3 Suppl 4):32-41. PubMed ID: 3289211 [No Abstract] [Full Text] [Related]
12. Cyclosporine in lamellar ichthyosis. Ho VC; Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Voorhees JJ Arch Dermatol; 1989 Apr; 125(4):511-4. PubMed ID: 2649010 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of cyclosporine treatment in severe psoriasis: a clinical and immunologic study. Finzi AF; Mozzanica N; Cattaneo A; Chiappino G; Pigatto PD J Am Acad Dermatol; 1989 Jul; 21(1):91-7. PubMed ID: 2787338 [TBL] [Abstract][Full Text] [Related]
14. Short-term changes in renal function, blood pressure, and electrolyte levels in patients receiving cyclosporine for dermatologic disorders. Gupta AK; Rocher LL; Schmaltz SP; Goldfarb MT; Brown MD; Ellis CN; Voorhees JJ Arch Intern Med; 1991 Feb; 151(2):356-62. PubMed ID: 1992963 [TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. Brynskov J; Freund L; Rasmussen SN; Lauritsen K; de Muckadell OS; Williams N; MacDonald AS; Tanton R; Molina F; Campanini MC N Engl J Med; 1989 Sep; 321(13):845-50. PubMed ID: 2671739 [TBL] [Abstract][Full Text] [Related]
16. Treatment of resistant severe psoriasis with systemic cyclosporine. Picascia DD; Garden JM; Freinkel RK; Roenigk HH J Am Acad Dermatol; 1987 Sep; 17(3):408-14. PubMed ID: 3655020 [TBL] [Abstract][Full Text] [Related]
17. Study of T helper (17) and T regulatory cells in psoriatic patients receiving live attenuated varicella vaccine therapy in a randomized controlled trial. El-Darouti MA; Hegazy RA; Abdel Hay RM; Rashed LA Eur J Dermatol; 2014; 24(4):464-9. PubMed ID: 25119950 [TBL] [Abstract][Full Text] [Related]
18. Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study. Micali G; Wilsmann-Theis D; Mallbris L; Gallo G; Marino V; Brault Y; Germain JM Acta Derm Venereol; 2015 Jan; 95(1):57-61. PubMed ID: 24682319 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study. Papp K; Bissonnette R; Rosoph L; Wasel N; Lynde CW; Searles G; Shear NH; Huizinga RB; Maksymowych WP Lancet; 2008 Apr; 371(9621):1337-42. PubMed ID: 18424323 [TBL] [Abstract][Full Text] [Related]
20. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]